Dermapharm Holding SE buy Snowman
Start price
16.06.21
/
50%
€71.65
Target price
16.06.22
€86.00
Performance (%)
-30.50%
End price
20.05.22
€49.80
Summary
This prediction ended on 20.05.22 with a price of €49.80. Massive losses of -30.50% were the result for the BUY prediction by Snowman. Snowman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 0.629% | 0.629% | 18.694% | -14.347% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by Snowman for this prediction
In the thread Dermapharm Holding SE diskutieren
Kursziel geändert auf 86,0